https://www.yna.co.kr/view/AKR20201126037451017
Jee-Soo Lee, So Yeon Kim, Taek Soo Kim, Ki Ho Hong, Nam-Hee Ryoo, Jaehyeon Lee, Jae Hyeon Park, Sung Im Cho, Man Jin Kim, Young-gon Kim, Boram Kim, Ho Seob Shin, Hyeon Sae Oh, Myoung-Seock Seo, Tae-Rin Gwon, Yeonjae Kim, Jun-Sun Park, Bum Sik Chin, Wan Beom Park, Sung Sup Park, Moon-Woo Seong, Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019, Clinical Infectious Diseases, , ciaa1421,
https://doi.org/10.1093/cid/ciaa1421
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1421/5997517
https://www.yna.co.kr/view/AKR20201121002851088
https://www.yna.co.kr/view/AKR20201123126700009
https://youtu.be/p07Ibo-Z988
https://www.cell.com/matter/fulltext/S2590-2385(20)30616-0
대부분 전문가들은 아직은 변이가 있었어도 현재 임상 중인 백신들 효과에 문제가 없을 수준이라고 합니다만,
부정적으로 보면, 백신 효과가 얼마나 갈지, 나중에는 차선책으로 독감처럼 계속 다른 백신으로 맞아야 하는 것은 아닌가 걱정이 생기기도 합니다.